Sutro Biopharma (STRO) News Today → Exposed: 3 CENT Crypto to Explode June 24th? (From True Market Insiders) (Ad) Free STRO Stock Alerts $3.71 -0.05 (-1.33%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 2:08 AM | americanbankingnews.comSutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.50 Consensus Price Target from BrokeragesJune 6 at 1:36 AM | marketbeat.comSutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Rating of "Buy" from AnalystsShares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have been given an average rating of "Buy" by the eight brokerages that are currently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average 12 month target price among broJune 3, 2024 | prnewswire.comVGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipelineMay 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Athira Pharma (ATHA) and Taysha Gene Therapies (TSHA)May 15, 2024 | markets.businessinsider.comBuy Rating on Sutro Biopharma: Promising Trials and Market Expansion Potential for LuveltaMay 15, 2024 | marketbeat.comSutro Biopharma's (STRO) "Outperform" Rating Reaffirmed at OppenheimerOppenheimer reiterated an "outperform" rating and set a $10.00 price target on shares of Sutro Biopharma in a report on Wednesday.May 14, 2024 | finanznachrichten.deSutro Biopharma, Inc.: Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated MilestonesMay 13, 2024 | msn.comSTRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024May 13, 2024 | globenewswire.comSutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated MilestonesMay 13, 2024 | finance.yahoo.comThe past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitableMay 8, 2024 | markets.businessinsider.comExpert Outlook: Sutro Biopharma Through The Eyes Of 10 AnalystsMay 8, 2024 | msn.comB of A Securities Initiates Coverage of Sutro Biopharma (STRO) with Buy RecommendationMay 8, 2024 | msn.comBofA starts Sutro at buy, cites ovarian cancer drug candidateApril 30, 2024 | marketbeat.comSutro Biopharma (NASDAQ:STRO) Given "Outperform" Rating at WedbushWedbush reaffirmed an "outperform" rating and issued a $8.00 price target on shares of Sutro Biopharma in a research report on Tuesday.April 30, 2024 | globenewswire.comSutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 TrialApril 17, 2024 | msn.comSutro Biopharma (STRO) Price Target Decreased by 6.45% to 13.15April 5, 2024 | marketbeat.comQ1 2024 EPS Estimates for Sutro Biopharma, Inc. (NASDAQ:STRO) Increased by AnalystSutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Analysts at Wedbush increased their Q1 2024 earnings estimates for shares of Sutro Biopharma in a research report issued on Tuesday, April 2nd. Wedbush analyst D. Nierengarten now expects that the company will earn ($0.73) per share for the quarApril 3, 2024 | marketbeat.comSutro Biopharma's (STRO) "Outperform" Rating Reaffirmed at WedbushWedbush reissued an "outperform" rating and set a $8.00 target price on shares of Sutro Biopharma in a report on Wednesday.April 3, 2024 | marketbeat.comTruist Financial Lowers Sutro Biopharma (NASDAQ:STRO) Price Target to $18.00Truist Financial decreased their price objective on shares of Sutro Biopharma from $25.00 to $18.00 and set a "buy" rating for the company in a research note on Wednesday.April 3, 2024 | markets.businessinsider.comSutro Biopharma Buy Rating Justified by Strategic Partnerships and Promising PipelineApril 2, 2024 | finance.yahoo.comSutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts SubstantiallyApril 2, 2024 | markets.businessinsider.comIpsen Secures Exclusive Global Rights Of Sutro Biopharma's STRO-003 ADC In Up To $900 Mln DealApril 2, 2024 | msn.comIpsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADCApril 2, 2024 | globenewswire.comSutro Biopharma Announces Pricing of $75 Million Underwritten OfferingApril 2, 2024 | marketwatch.comIpsen, Sutro Biopharma Enter Into Licensing Deal Valued at Up to $900 MlnApril 2, 2024 | globenewswire.comIpsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumorsApril 1, 2024 | msn.comPenny Stock Sutro Biopharma (NASDAQ:STRO): Intriguing Play for Biotech InvestorsMarch 28, 2024 | marketbeat.comHC Wainwright Brokers Lower Earnings Estimates for Sutro Biopharma, Inc. (NASDAQ:STRO)Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Analysts at HC Wainwright lowered their Q1 2024 earnings per share (EPS) estimates for shares of Sutro Biopharma in a note issued to investors on Tuesday, March 26th. HC Wainwright analyst A. Fein now expects that the company will post earningsMarch 27, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Sutro Biopharma (STRO), Catalyst Pharma (CPRX)March 27, 2024 | markets.businessinsider.comNavigating 4 Analyst Ratings For Sutro BiopharmaMarch 27, 2024 | finance.yahoo.comSutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic AdvancesMarch 27, 2024 | marketbeat.comOppenheimer Reaffirms "Outperform" Rating for Sutro Biopharma (NASDAQ:STRO)Oppenheimer reaffirmed an "outperform" rating and issued a $10.00 target price on shares of Sutro Biopharma in a report on Wednesday.March 26, 2024 | marketbeat.comSutro Biopharma (NASDAQ:STRO) Price Target Lowered to $8.00 at WedbushWedbush reduced their target price on Sutro Biopharma from $12.00 to $8.00 and set an "outperform" rating on the stock in a research note on Tuesday.March 26, 2024 | finanznachrichten.deSutro Biopharma, Inc.: Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated MilestonesMarch 26, 2024 | markets.businessinsider.comTD Cowen Sticks to Its Buy Rating for Sutro Biopharma (STRO)March 26, 2024 | markets.businessinsider.comSutro Biopharma Buy Rating Affirmed on Strong Financials and Promising Clinical PipelineMarch 25, 2024 | investorplace.comSTRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023March 25, 2024 | globenewswire.comSutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated MilestonesMarch 9, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Has $10.78 Million Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO)Adage Capital Partners GP L.L.C. lifted its stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 1,275.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,105,132 shares of the company's stockMarch 6, 2024 | marketbeat.comRubric Capital Management LP Sells 703,934 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO)Rubric Capital Management LP cut its stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 17.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,344,810 shares of the company's stock after sellFebruary 26, 2024 | marketbeat.comSutro Biopharma, Inc. (NASDAQ:STRO) Stake Raised by Acadian Asset Management LLCAcadian Asset Management LLC lifted its position in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 18.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 773,867 shares of the company's stock after buying an additionalFebruary 16, 2024 | marketbeat.comSutro Biopharma, Inc. (NASDAQ:STRO) Short Interest UpdateSutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 2,610,000 shares, a growth of 8.8% from the January 15th total of 2,400,000 shares. Based on an average daily volume of 908,800 shares, the days-to-cover ratio is currently 2.9 days.February 10, 2024 | msn.comSutro Biopharma Expands Share Offering, Raises $129MFebruary 2, 2024 | marketbeat.comSutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of "Moderate Buy" by AnalystsSutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the cJanuary 9, 2024 | markets.businessinsider.comSutro Biopharma: Hold Rating Maintained Amid Near-Term Uncertainties and Market Potential AmbiguitiesJanuary 6, 2024 | markets.businessinsider.comBuy Rating Justified: Sutro Biopharma’s Luvelta Shows Promise in PROC Treatment and BeyondJanuary 5, 2024 | marketbeat.comSutro Biopharma (NASDAQ:STRO) Stock Rating Reaffirmed by WedbushWedbush restated an "outperform" rating and set a $12.00 target price on shares of Sutro Biopharma in a research report on Friday.January 4, 2024 | finance.yahoo.comSutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADCDecember 29, 2023 | benzinga.comSutro Biopharma Stock (NASDAQ:STRO) Dividends: History, Yield and DatesDecember 18, 2023 | finance.yahoo.comSutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift Too Get Sutro Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for STRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Jeff Bezos & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market… Click here for the details STRO Media Mentions By Week STRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STRO News Sentiment▼0.670.76▲Average Medical News Sentiment STRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STRO Articles This Week▼31▲STRO Articles Average Week Get Sutro Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for STRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cullinan Therapeutics News BioCryst Pharmaceuticals News Tarsus Pharmaceuticals News 4D Molecular Therapeutics News Ginkgo Bioworks News Autolus Therapeutics News Humacyte News Immatics News Inhibrx News Relay Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STRO) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored📈 Alert: Gold Reaches New All Time High Amidst Inflation DataCentral Banks Have bought More Gold in the last 2 years than in all of history combined. That's right, the SAM...All American Assets | Sponsored